Pfizer loses attempt to force journals to reveal peer review commentsBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39538.486389.DB (Published 03 April 2008) Cite this as: BMJ 2008;336:743
- Clare Dyer
A US federal judge in Illinois has rejected a bid by the drug company Pfizer to force two leading medical journals to hand over confidential documents relating to peer review of studies on its cyclo-oxygenase-2 inhibitors valdecoxib (Bextra) and celecoxib (Celebrex).
The company sought the documents from a number of journals, including the BMJ, to help it defend 3000 product liability lawsuits over alleged side effects of the two drugs.
But the journals have strongly contested the move as a threat to the process of peer …
Log in using your username and password
Log in through your institution
Sign up for a free trial